Crypto prices
Loading prices…
CoinGecko · USD · 24h
Topic

Latest news — Page 104

LB Pharmaceuticals Posts $1.79 Loss Per Share in Third Quarter

Research and development expenses rose to $51.516 million as the company advanced two clinical trials. It expects its $403.760 million in cash and investments to fund planned operations beyond the second quarter of 2029.

Nov 7, 20261 min read
Loading…